共 208 条
[1]
Maeda K(2014)Brexpiprazole I: J Pharmacol Exp Ther 350 589-604
[2]
Sugino H(2015) and Am J Psychiatry 172 870-880
[3]
Akazawa H(2015) characterization of a novel serotonin–dopamine activity modulator Schizophr Res 164 127-135
[4]
Amada N(2017)Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled trial Int J Neuropsychopharmacol 20 11-21
[5]
Shimada J(2015)A multicenter, randomized, double-blind, controlled Phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia J Clin Psychiatry 76 1224-1231
[6]
Futamura T(2015)Efficacy and safety of brexpiprazole (OPC-34712) as maintenance treatment in adults with schizophrenia: a randomized, double-blind, placebo-controlled study J Clin Psychiatry 76 1232-1240
[7]
Yamashita H(2018)Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a Phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants Curr Med Res Opin 34 633-642
[8]
Ito N(1988)Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a Phase 3, randomized, double-blind study Arch Gen Psychiatry 45 71-76
[9]
McQuade RD(1993)Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study Biol Psychiatry 33 227-235
[10]
Mørk A(2000)Central D Am J Psychiatry 157 514-520